Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Journal of Psychiatric Research
|
May 11, 2012
Frontal and right temporal activations correlate negatively with depression severity during verbal fluency task: a multi-channel near-infrared spectroscopy study
Takamasa Noda, Sumiko Yoshida, Taro Matsuda, et al.
The Journal of Headache and Pain
|
September 19, 2021
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
Koichi Hirata, Fumihiko Sakai, Takao Takeshima, et al.
Neurology and Therapy
|
September 12, 2023
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Shigekazu Kitamura, Takao Takeshima, Daishi Yui, et al.
BMJ Open
|
August 19, 2023
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Brain and Behavior
|
February 24, 2022
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Journal of Psychiatric Research
|
May 11, 2012
Frontal and right temporal activations correlate negatively with depression severity during verbal fluency task: a multi-channel near-infrared spectroscopy study
Takamasa Noda, Sumiko Yoshida, Taro Matsuda, et al.
The Journal of Headache and Pain
|
September 19, 2021
Efficacy and safety of erenumab in Japanese migraine patients with prior preventive treatment failure or concomitant preventive treatment: subgroup analyses of a phase 3, randomized trial
Koichi Hirata, Fumihiko Sakai, Takao Takeshima, et al.
Neurology and Therapy
|
September 12, 2023
Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
Shigekazu Kitamura, Takao Takeshima, Daishi Yui, et al.
BMJ Open
|
August 19, 2023
Long-term efficacy and safety of erenumab in Japanese patients with episodic and chronic migraine: results from a 28-week open-label treatment period of a randomised trial
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Brain and Behavior
|
February 24, 2022
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies
Koichi Hirata, Takao Takeshima, Fumihiko Sakai, et al.
Page
of 2